v3.26.1
Share-Based Payments
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Share-Based Payments Share-Based Payments
Share-based compensation expense is as follows (dollars in thousands):
Three Months Ended
March 31,
20262025
(unaudited)
Research and development$1,535 $1,412 
Selling, general and administrative6,945 6,656 
Total$8,480 $8,068 
The Company has $12.3 million of unrecognized compensation expense related to CVRs granted to holders of the accelerated Sage equity awards as of March 31, 2026. This unrecognized compensation expense will be recognized if and when the milestones associated with the CVRs become probable of achievement.
Stock Options
The following table summarizes stock option activities:
Number of
Options
Weighted
Average
Exercise Price
Weighted
Average
Remaining
Contractual
Term (in years)
Outstanding, December 31, 20256,343,009 $32.63 6.3
Granted 892,392 $50.20 
Exercised (443,350)$30.83 
Forfeited (19,508)$39.90 
Outstanding, March 31, 2026 (unaudited)6,772,543 $35.04 6.7
As of March 31, 2026 (unaudited):
Vested and expected to vest6,772,543 $35.04 6.7
Exercisable 4,125,746 $32.44 5.3
As of December 31, 2025:
Vested and expected to vest6,343,009 $32.63 6.3
Exercisable3,636,073 $32.08 4.8
Restricted Stock Units
The following table summarizes restricted stock unit (RSU) activities:
Number of
RSUs
Weighted Average
Grant Date Fair Value per Share
Nonvested, December 31, 2025396,693 $32.98 
Granted122,609 $50.20 
Vested(163,690)$33.46 
Forfeited(135)$50.20 
Nonvested, March 31, 2026 (unaudited)355,477 $38.70 
Performance Share Units
The following table summarizes performance share unit (PSU) activities:
Performance-Based Units
Number of PSUsWeighted
Average
Grant Date Fair Value per Share
Nonvested, December 31, 2025390,496 $30.80 
Granted— $— 
Vested(62,590)$27.33 
Forfeited(55,840)$28.19 
Nonvested, March 31, 2026 (unaudited)272,066$32.13